Risk and response adapted treatment for early stage Hodgkin's lymphoma (ESHL): Preliminary results of an Australasian Leukaemia & Lymphoma Group/Trans-Tasman Radiation Oncology Group study
2004 ◽
Vol 22
(14_suppl)
◽
pp. 6531-6531
◽